Loading...
DexCom, Inc.
DXCM•NASDAQ
HealthcareMedical - Devices
$86.67
$0.93(1.08%)
DexCom, Inc. (DXCM) Financial Performance & Statements
Review DexCom, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
11.34%
↑ 11.34%
Operating Income Growth
0.38%
↑ 0.38%
Net Income Growth
6.41%
↑ 6.41%
Operating Cash Flow Growth
32.20%
↑ 32.20%
Operating Margin
15.25%
↑ 15.25%
Gross Margin
59.39%
↑ 59.39%
Net Profit Margin
12.90%
↑ 12.90%
ROE
24.38%
↑ 24.38%
ROIC
17.03%
↑ 17.03%
DexCom, Inc. (DXCM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for DexCom, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.11B | $994.20M | $1.004B | $921.00M |
| Cost of Revenue | $459.50M | $400.40M | $377.60M | $359.10M |
| Gross Profit | $654.00M | $593.80M | $626.70M | $561.90M |
| Gross Profit Ratio | $0.59 | $0.60 | $0.62 | $0.61 |
| R&D Expenses | $139.50M | $135.40M | $136.00M | $141.50M |
| SG&A Expenses | $327.40M | $306.40M | $332.70M | $319.30M |
| Operating Expenses | $465.10M | $441.80M | $468.70M | $460.80M |
| Total Costs & Expenses | $924.60M | $842.20M | $846.30M | $819.90M |
| Interest Income | $29.70M | $32.00M | $36.20M | $36.30M |
| Interest Expense | $4.90M | $4.70M | $4.80M | $4.60M |
| Depreciation & Amortization | $57.80M | $55.30M | $52.10M | $52.50M |
| EBITDA | $274.00M | $237.40M | $244.70M | $189.60M |
| EBITDA Ratio | $0.25 | $0.24 | $0.24 | $0.21 |
| Operating Income | $188.90M | $152.00M | $158.00M | $101.10M |
| Operating Income Ratio | $0.17 | $0.15 | $0.16 | $0.11 |
| Other Income/Expenses (Net) | $22.40M | $25.40M | $29.80M | $31.40M |
| Income Before Tax | $211.30M | $177.40M | $187.80M | $132.50M |
| Income Before Tax Ratio | $0.19 | $0.18 | $0.19 | $0.14 |
| Income Tax Expense | $59.60M | $42.80M | $44.30M | -$13.90M |
| Net Income | $151.70M | $134.60M | $143.50M | $146.40M |
| Net Income Ratio | $0.14 | $0.14 | $0.14 | $0.16 |
| EPS | $0.39 | $0.35 | $0.36 | $0.38 |
| Diluted EPS | $0.38 | $0.34 | $0.35 | $0.36 |
| Weighted Avg Shares Outstanding | $399.33M | $394.20M | $399.20M | $390.20M |
| Weighted Avg Shares Outstanding (Diluted) | $406.70M | $410.20M | $416.80M | $416.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan